Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 122

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 122
---
aken’s ownership of shares of Aadi’s capital stock; |

| • |     | brokers’ fees and expenses; |

| • |     | the absence of any vote or consent by holders of Kaken capital stock required for the approval of the Divestiture 
 Agreement or the Divestiture;                                                                                     |

| • |     | Kaken’s financial capability to make all payments contemplated by the Divestiture Agreement, pay all fees                                                        
 and expenses required to be paid at completion of the Divestiture and the resources and capabilities to perform its obligations under the Divestiture Agreement; |

| • |     | the absence of stockholder and management arrangements; and |

| • |     | Kaken’s investment intent and status as an “accredited investor” as defined in Regulation D 
 promulgated under the Securities Act.                                                       |

Under the Divestiture Agreement, Aadi and Aadi Sub acknowledge that Kaken and its subsidiaries have not made any representations or warranties other than in connection with the Divestiture Agreement or the Divestiture and expressly disclaim reliance on any representation, warranty or other information regarding Kaken, other than those expressly set forth in the Divestiture Agreement. Certain of the representations and warranties contained in the Divestiture Agreement will survive for designated periods of time after the completion of the Divestiture as further described in the section of this proxy statement captioned “ The Divestiture Agreement—Indemnification.” Conduct of Business Pending the Divestiture Other than as expressly contemplated by the Divestiture Agreement, set forth in the confidential disclosure letter to the Divestiture Agreement, as required by applicable law or approved by Kaken (which approval, under the terms of the Divestiture Agreement, may not be unreasonably withheld, conditioned or delayed), from the date of - 79 -

the Divestiture Agreement to the completion of the Divestiture (or termination of the Divestiture Agreement), Aadi has agreed to, and agreed to cause Aadi Sub to, subject to certain exceptions, use its reasonable best efforts to:

| • |     | conduct its business and operations in the ordinary course of business; |

| • |     | preserve intact Aadi Sub’s material assets, properties, contracts and business organizations; |

| • |     | keep available the services of Aadi Sub’s current officers and key employees; and |

| • |     | preserve the current relationships with material customers, suppliers, distributors, lessors, licensors, 
 licensees,